StockData
Equillium, Inc. logo

Equillium, Inc. (EQ) stock

EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.21+0.06 (+5.22%)

Close on Nov 17, 2026Market cap $76.72MP/E –Yield –

Equillium operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Equillium's operating income for the twelve months ending Jun 30, 2026 was -$19.30M. For fiscal 2025 it was -$23.63M. The highest annual figure on record is -$8.27M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.63M–
FY2024Dec 31, 2024-$8.27M–
FY2023Dec 31, 2023-$14.52M–
FY2022Dec 31, 2022-$62.08M–
FY2021Dec 31, 2021-$37.79M–
FY2020Dec 31, 2020-$29.55M–
FY2019Dec 31, 2019-$26.73M–
FY2018Dec 31, 2018-$8.62M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.16M–
Q1 FY2026Mar 31, 2026-$5.61M–
Q4 FY2025Dec 31, 2025-$3.96M–
Q3 FY2025Sep 30, 2025-$4.58M–
Q2 FY2025Jun 30, 2025-$6.23M–
Q1 FY2025Mar 31, 2025-$8.87M–
Q4 FY2024Dec 31, 2024-$4.70M–
Q3 FY2024Sep 30, 2024-$679.00K–
Q2 FY2024Jun 30, 2024-$100.00K–
Q1 FY2024Mar 31, 2024-$2.79M–
Q4 FY2023Dec 31, 2023-$3.20M-256.7%
Q3 FY2023Sep 30, 2023-$3.62M–
Q2 FY2023Jun 30, 2023-$3.59M–
Q1 FY2023Mar 31, 2023-$4.11M–
Q4 FY2022Dec 31, 2022$2.04M–
Q3 FY2022Sep 30, 2022-$13.24M–
Q2 FY2022Jun 30, 2022-$13.55M–
Q1 FY2022Mar 31, 2022-$37.33M–
Q4 FY2021Dec 31, 2021-$10.39M–
Q3 FY2021Sep 30, 2021-$9.86M–
Q2 FY2021Jun 30, 2021-$8.84M–
Q1 FY2021Mar 31, 2021-$8.70M–
Q4 FY2020Dec 31, 2020-$8.97M–
Q3 FY2020Sep 30, 2020-$6.52M–
Q2 FY2020Jun 30, 2020-$6.61M–
Q1 FY2020Mar 31, 2020-$7.45M–
Q4 FY2019Dec 31, 2019-$7.62M–
Q3 FY2019Sep 30, 2019-$6.32M–
Q2 FY2019Jun 30, 2019-$6.44M–
Q1 FY2019Mar 31, 2019-$6.35M–
Q4 FY2018Dec 31, 2018-$4.23M–
Q3 FY2018Sep 30, 2018-$2.23M–
Q2 FY2018Jun 30, 2018-$1.13M–
Q1 FY2018Mar 31, 2018-$1.04M–
Q3 FY2017Sep 30, 2017-$83.71K–

More Equillium figures

See a number that looks wrong?